Passage Bio Ownership | Who Owns Passage Bio?

Passage Bio Ownership Summary

Passage Bio is owned by 10.22% institutional investors, 0.49% insiders, and 89.29% retail investors. Lynx1 capital management lp is the largest institutional shareholder, holding 14.99% of PASG shares. Worldwide Healthcare Ord is the top mutual fund, with 3.28% of its assets in Passage Bio shares.

PASG Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Passage Bio	10.22%	0.49%	89.29%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Lynx1 capital management lp	9.26M	14.99%	$5.25M
Orbimed advisors	7.40M	11.99%	$4.20M
Vestal point capital, lp	6.10M	9.88%	$3.46M
New leaf venture partners	2.50M	4.04%	$1.42M
Vanguard group	2.07M	3.35%	$1.17M
Tang capital management	1.50M	2.43%	$850.65K
Renaissance	1.38M	2.24%	$783.43K
Acadian asset management	942.90K	1.53%	$533.00K
Blackrock	817.53K	1.45%	$649.28K
Blackrock funding, inc. /de	722.30K	1.17%	$409.61K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lynx1 capital management lp	9.26M	1.97%	$5.25M
New leaf venture partners	2.50M	1.89%	$1.42M
Vestal point capital, lp	6.10M	0.21%	$3.46M
Orbimed advisors	7.40M	0.09%	$4.20M
Tang capital management	1.50M	0.06%	$850.65K
Ground swell capital	25.42K	0.02%	$14.42K
Shay capital	225.26K	0.02%	$127.75K
Dlk investment management	53.00K	0.01%	$30.06K
Bridgeway capital management	556.14K	0.01%	$315.39K
Rbf capital	142.81K	0.00%	$80.99K

Top Buyers

Holder	Shares	% Assets	Change
Lynx1 capital management lp	9.26M	1.97%	830.00K
Shay capital	225.26K	0.02%	133.00K
Jane street group	78.19K	-	65.92K
Tower research capital llc (trc)	54.48K	0.00%	49.45K
Squarepoint ops	64.10K	-	36.17K

Top Sellers

Holder	Shares	% Assets	Change
Versant venture management	-	-	-4.03M
Orbimed advisors	7.40M	0.09%	-2.42M
Acuitas investments	-	-	-471.81K
Affinity asset advisors	-	-	-264.27K
Two sigma advisers, lp	-	-	-209.60K

New Positions

Holder	Shares	% Assets	Change	Value
Ground swell capital	25.42K	0.02%	25.42K	$14.42K
Hrt financial lp	13.85K	-	13.85K	$7.00K
Virtu financial	10.29K	0.00%	10.29K	$6.00K
Atria wealth solutions	10.00K	0.00%	10.00K	$5.67K
Mai capital management	4.00K	-	4.00K	$2.27K

Sold Out

Holder	Change
Qube research	-4.00
Federation des caisses desjardins du quebec	-10.00
Northwestern mutual wealth management	-64.00
Wells fargo & company/mn	-309.00
Global retirement partners	-400.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	13	-70.45%	6,312,660	-83.67%	10	0.26%	5	-72.22%	4	-42.86%
Sep 30, 2024	44	-	38,667,152	2.24%	62	1.39%	19	72.73%	7	-36.36%
Jun 30, 2024	44	-12.00%	37,821,661	-0.07%	67	1.42%	11	-45.00%	11	-15.38%
Mar 31, 2024	50	-	37,847,261	27.02%	68	2.33%	20	-4.76%	13	30.00%
Dec 31, 2023	50	2.04%	29,797,319	-0.77%	54	1.80%	21	40.00%	10	-23.08%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Worldwide Healthcare Ord	2.03M	3.28%	-
Vanguard US Total Market Shares ETF	1.50M	2.41%	-
Vanguard Total Stock Mkt Idx Inv	1.50M	2.41%	-
Vanguard Institutional Extnd Mkt Idx Tr	493.23K	0.79%	-
Bridgeway Ultra-Small Company	416.04K	0.67%	-
Galileo - Biotech Innovation Fund S USD	412.28K	0.66%	-
Fidelity Extended Market Index	283.97K	0.46%	-1.81K
Bridgeway Ultra-Small Company Market	140.10K	0.23%	-
iShares Micro-Cap ETF	112.74K	0.18%	-
Fidelity Total Market Index	81.32K	0.13%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 11, 2025	Borthwick Kathleen	CFO	Sell	$1.69K
Jan 14, 2025	ORBIMED ADVISORS LLC	-	Sell	$47.41K
Jan 10, 2025	ORBIMED ADVISORS LLC	-	Sell	$83.30K
Jan 13, 2025	ORBIMED ADVISORS LLC	-	Sell	$11.51K
Jan 07, 2025	ORBIMED ADVISORS LLC	-	Sell	$37.30K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	7
2024 Q4	4	6
2024 Q3	-	4
2024 Q2	-	-
2024 Q1	-	5

PASG Ownership FAQ

Who Owns Passage Bio?

Passage Bio shareholders are primarily institutional investors at 10.22%, followed by 0.49% insiders and 89.29% retail investors. The average institutional ownership in Passage Bio's industry, Biotech Stocks , is 68.48%, which Passage Bio falls below.

Who owns the most shares of Passage Bio?

Passage Bio’s largest shareholders are Lynx1 capital management lp (9.26M shares, 14.99%), Orbimed advisors (7.4M shares, 11.99%), and Vestal point capital, lp (6.1M shares, 9.88%). Together, they hold 36.85% of Passage Bio’s total shares outstanding.

Does Blackrock own Passage Bio?

Yes, BlackRock owns 1.45% of Passage Bio, totaling 817.53K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 649.28K$. In the last quarter, BlackRock decreased its holdings by -105K shares, a -11.38% change.

Who is Passage Bio’s biggest shareholder by percentage of total assets invested?

Lynx1 capital management lp is Passage Bio’s biggest shareholder by percentage of total assets invested, with 1.97% of its assets in 9.26M Passage Bio shares, valued at 5.25M$.

Who is the top mutual fund holder of Passage Bio shares?

Worldwide Healthcare Ord is the top mutual fund holder of Passage Bio shares, with 3.28% of its total shares outstanding invested in 2.03M Passage Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools